Lothar Germeroth
Algemeen Directeur bij Juno Therapeutics GmbH
Oorsprong van het eerstegraads netwerk van Lothar Germeroth
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Repairon GmbH
 Repairon GmbH Repairon GmbH engages in the development, manufacture, and commercialization of induced pluripotent stem cell based tissues for organ repair. It offers therapeutic products such as tissue patches and pouches for the treatment of patients with heart failure caused by ischemic and dilatative cardiomyopathies. The company was founded by Wolfram Zimmermann in 2004 and is headquartered in Goettingen, Germany.
2
| Private Company | 2 | |
Juno Therapeutics GmbH
 Juno Therapeutics GmbH BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Juno Therapeutics GmbH is a German company that researches and develops cellular therapies. The company is based in Munich, Germany. The CEOs of the company are David Walter Pignolet, Lothar Germeroth. Juno Therapeutics was acquired by Juno Therapeutics, Inc., part of Bristol Myers Squibb Co. from March 07, 2018 on May 11, 2015 for $232.80 million.
1
| Subsidiary | Biotechnology | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Lothar Germeroth via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Celgene SRL (Belgium)
 Celgene SRL (Belgium) Miscellaneous Commercial ServicesCommercial Services Part of Bristol Myers Squibb Co., Celgene SRL (Belgium) is a Belgian company that engages in research and development on biotechnology. The company is based in Watermaal-Bosvoorde, Belgium. The CEOs are Katherine Reynolds Kelly, David Walter Pignolet. The company was founded in 2006. | Miscellaneous Commercial Services | Chief Executive Officer | |
Celgene Ltd.
 Celgene Ltd. Pharmaceuticals: MajorHealth Technology Celgene Ltd. engages in the development of human pharmaceuticals and agrochemicals. It focuses on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. The company was founded on June 2, 2015 and is headquartered in Uxbridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
| België | 2 |
| Verenigd Koninkrijk | 2 |
| Frankrijk | 2 |
Sectoraal
| Health Technology | 3 |
| Commercial Services | 2 |
Operationeel
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Founder | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| David Walter Pignolet | 4 |
| Rainer Knaus | 1 |
| Wolfram Zimmermann | 1 |
- Beurs
- Insiders
- Lothar Germeroth
- Bedrijfsconnecties
